Literature DB >> 23760708

Clinically relevant genetic advances in endocrinology.

Angela Rogers1, Rajesh V Thakker.   

Abstract

Entities:  

Keywords:  Diagnosis; MEN; mutational analysis; personalised medicine; screening

Mesh：

Substances：

Year:  2013        PMID： 23760708      PMCID： PMC5922678          DOI： 10.7861/clinmedicine.13-3-299

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN： 1470-2118            Impact factor:   2.659


× No keyword cloud information.
  18 in total

1.  Presence of fetal DNA in maternal plasma and serum.

Authors:  Y M Lo; N Corbetta; P F Chamberlain; V Rai; I L Sargent; C W Redman; J S Wainscoat
Journal:  Lancet       Date:  1997-08-16       Impact factor: 79.321

Review 2.  Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1).

Authors:  Rajesh V Thakker; Paul J Newey; Gerard V Walls; John Bilezikian; Henning Dralle; Peter R Ebeling; Shlomo Melmed; Akihiro Sakurai; Francesco Tonelli; Maria Luisa Brandi
Journal:  J Clin Endocrinol Metab       Date:  2012-06-20       Impact factor: 5.958

3.  Medullary thyroid cancer: options for systemic therapy of metastatic disease?

Authors:  Renato G Martins; Joseph G Rajendran; Peter Capell; David R Byrd; David A Mankoff
Journal:  J Clin Oncol       Date:  2006-03-20       Impact factor: 44.544

Review 4.  Redefining disease.

Authors:  John Bell
Journal:  Clin Med (Lond)       Date:  2010-12       Impact factor: 2.659

Review 5.  46,XX DSD: the masculinised female.

Authors:  Richard J Auchus; Alice Y Chang
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2010-04       Impact factor: 4.690

6.  Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A.

Authors:  Michael A Skinner; Jeffrey A Moley; William G Dilley; Kouros Owzar; Mary K Debenedetti; Samuel A Wells
Journal:  N Engl J Med       Date:  2005-09-15       Impact factor: 91.245

Review 7.  Prenatal treatment of congenital adrenal hyperplasia-not standard of care.

Authors:  Selma Feldman Witchel; Walter L Miller
Journal:  J Genet Couns       Date:  2012-05-26       Impact factor: 2.537

8.  Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial.

Authors:  Samuel A Wells; Bruce G Robinson; Robert F Gagel; Henning Dralle; James A Fagin; Massimo Santoro; Eric Baudin; Rossella Elisei; Barbara Jarzab; James R Vasselli; Jessica Read; Peter Langmuir; Anderson J Ryan; Martin J Schlumberger
Journal:  J Clin Oncol       Date:  2011-10-24       Impact factor: 44.544

9.  Vandetanib for the treatment of patients with locally advanced or metastatic hereditary medullary thyroid cancer.

Authors:  Samuel A Wells; Jessica E Gosnell; Robert F Gagel; Jeffrey Moley; David Pfister; Julie A Sosa; Michael Skinner; Annetta Krebs; James Vasselli; Martin Schlumberger
Journal:  J Clin Oncol       Date:  2010-01-11       Impact factor: 44.544

Review 10.  Genetics of congenital adrenal hyperplasia.

Authors:  Nils Krone; Wiebke Arlt
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2009-04       Impact factor: 4.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.